Titre:
  • Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma.
Auteur:Rosa, Daniela Dornelles; Awada, Ahmad; Mano, Max S.; Selleslags, Jean; Lebrun, Fabienne; Gil, Thierry; Piccart-Gebhart, Martine; D'Hondt, Véronique
Informations sur la publication:Archives of gynecology and obstetrics, 278, 5, page (457-462)
Statut de publication:Publié, 2008-11
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Chemotherapy
Epithelial ovarian carcinoma
FOLFOX
Oxaliplatin
MeSH keywords:Aged
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Carcinoma -- drug therapy
Carcinoma -- pathology
Cohort Studies
Disease-Free Survival
Fallopian Tube Neoplasms -- drug therapy
Fallopian Tube Neoplasms -- pathology
Female
Fluorouracil -- adverse effects
Humans
Leucovorin -- adverse effects
Middle Aged
Neoplasm Staging
Organoplatinum Compounds -- administration & dosage
Organoplatinum Compounds -- adverse effects
Ovarian Neoplasms -- drug therapy
Ovarian Neoplasms -- pathology
Treatment Outcome
Note générale:Clinical Trial
Journal Article
Langue:Anglais
Identificateurs:urn:issn:0932-0067
info:doi/10.1007/s00404-008-0592-9
info:scp/51449084510
info:pmid/18273626